 Neoplasm Invasiveness
"Neoplasm Invasiveness" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Ability of neoplasms to infiltrate and actively destroy surrounding tissue.
| Descriptor ID |
D009361
|
| MeSH Number(s) |
C04.697.645 C23.550.727.645
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Invasiveness".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Invasiveness".
This graph shows the total number of publications written about "Neoplasm Invasiveness" by people in this website by year, and whether "Neoplasm Invasiveness" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1982 | 0 | 1 | 1 | | 1983 | 0 | 1 | 1 | | 1985 | 0 | 2 | 2 | | 1986 | 0 | 4 | 4 | | 1989 | 0 | 3 | 3 | | 1991 | 0 | 1 | 1 | | 1992 | 0 | 4 | 4 | | 1993 | 0 | 7 | 7 | | 1994 | 0 | 5 | 5 | | 1995 | 0 | 6 | 6 | | 1996 | 0 | 4 | 4 | | 1997 | 1 | 3 | 4 | | 1998 | 1 | 4 | 5 | | 1999 | 1 | 6 | 7 | | 2000 | 0 | 8 | 8 | | 2001 | 0 | 7 | 7 | | 2002 | 1 | 5 | 6 | | 2003 | 2 | 5 | 7 | | 2004 | 6 | 6 | 12 | | 2005 | 1 | 12 | 13 | | 2006 | 0 | 12 | 12 | | 2007 | 5 | 11 | 16 | | 2008 | 1 | 15 | 16 | | 2009 | 3 | 9 | 12 | | 2010 | 1 | 12 | 13 | | 2011 | 1 | 16 | 17 | | 2012 | 0 | 21 | 21 | | 2013 | 2 | 16 | 18 | | 2014 | 1 | 19 | 20 | | 2015 | 0 | 28 | 28 | | 2016 | 0 | 16 | 16 | | 2017 | 2 | 14 | 16 | | 2018 | 3 | 17 | 20 | | 2019 | 1 | 13 | 14 | | 2020 | 0 | 5 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Neoplasm Invasiveness" by people in Profiles.
-
Nooromid MJ, Thomas MA, Yoon DY, Eskandari MK, Peabody TD, Rodriguez HE. Outcomes of Sarcoma Resections Requiring Vascular Surgical Assistance: A Single-Center Experience. Vasc Endovascular Surg. 2020 Oct; 54(7):579-585.
-
van Leenders GJLH, van der Kwast TH, Grignon DJ, Evans AJ, Kristiansen G, Kweldam CF, Litjens G, McKenney JK, Melamed J, Mottet N, Paner GP, Samaratunga H, Schoots IG, Simko JP, Tsuzuki T, Varma M, Warren AY, Wheeler TM, Williamson SR, Iczkowski KA. The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma. Am J Surg Pathol. 2020 08; 44(8):e87-e99.
-
Dietz JR, Moran MS, Isakoff SJ, Kurtzman SH, Willey SC, Burstein HJ, Bleicher RJ, Lyons JA, Sarantou T, Baron PL, Stevens RE, Boolbol SK, Anderson BO, Shulman LN, Gradishar WJ, Monticciolo DL, Plecha DM, Nelson H, Yao KA. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat. 2020 Jun; 181(3):487-497.
-
Tien Y, Tsai CL, Hou WH, Chiang Y, Hsu FM, Tsai YC, Cheng JC. Targeting human epidermal growth factor receptor 2 enhances radiosensitivity and reduces the metastatic potential of Lewis lung carcinoma cells. Radiat Oncol. 2020 Mar 06; 15(1):58.
-
Smith BL, Lanahan CR, Specht MC, Kelly BN, Brown C, Strasfeld DB, Ferrer JM, Rai U, Tang R, Rice-Stitt T, Biernacka A, Brachtel EF, Gadd MA. Feasibility Study of a Novel Protease-Activated Fluorescent Imaging System for Real-Time, Intraoperative Detection of Residual Breast Cancer in Breast Conserving Surgery. Ann Surg Oncol. 2020 Jun; 27(6):1854-1861.
-
Schmid P, Rugo HS, Adams S, Schneeweiss A, Barrios CH, Iwata H, Diéras V, Henschel V, Molinero L, Chui SY, Maiya V, Husain A, Winer EP, Loi S, Emens LA. Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2020 01; 21(1):44-59.
-
ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer. J Am Coll Radiol. 2019 Nov; 16(11S):S417-S427.
-
Zhou Q, Wu X, Wang X, Yu Z, Pan T, Li Z, Chang X, Jin Z, Li J, Zhu Z, Liu B, Su L. The reciprocal interaction between tumor cells and activated fibroblasts mediated by TNF-a/IL-33/ST2L signaling promotes gastric cancer metastasis. Oncogene. 2020 02; 39(7):1414-1428.
-
Kohler H, Latteyer S, Hönes GS, Theurer S, Liao XH, Christoph S, Zwanziger D, Schulte JH, Kero J, Undeutsch H, Refetoff S, Schmid KW, Führer D, Moeller LC. Increased Anaplastic Lymphoma Kinase Activity Induces a Poorly Differentiated Thyroid Carcinoma in Mice. Thyroid. 2019 10; 29(10):1438-1446.
-
Pitroda SP, Weichselbaum RR. Integrated molecular and clinical staging defines the spectrum of metastatic cancer. Nat Rev Clin Oncol. 2019 09; 16(9):581-588.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|